You have 9 free searches left this month | for more free features.

cladribine

Showing 26 - 50 of 56

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell Trial in China (Chidamide, Cladribine, Gemcitabine)

Recruiting
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, T-Cell
  • Deyang, Deyang, China
  • +10 more
Jul 21, 2022

Hairy Cell Leukemia, Recurrent Hairy Cell Leukemia Trial in Houston (drug, other, biological)

Recruiting
  • Hairy Cell Leukemia
  • Recurrent Hairy Cell Leukemia
  • Cladribine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 20, 2020

Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo)

Completed
  • Relapsing-Remitting Multiple Sclerosis
  • Cladribine
  • Placebo
  • Boulder, Colorado
  • +116 more
Nov 10, 2020

Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blasts 10 Percent or More of Bone Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Cladribine
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

Mixed Phenotype Acute Leukemia, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

Completed
  • Mixed Phenotype Acute Leukemia
  • +6 more
  • Cladribine
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 21, 2020

Acute Myeloid Leukemia Trial in Saint Louis (Selinexor, Cladribine, G-CSF)

Completed
  • Acute Myeloid Leukemia
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 6, 2020

AML, Relapse Trial in Berne (Epacadostat, Cladribine, Cytarabine)

Withdrawn
  • AML
  • Relapse
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Sep 7, 2018

Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia-2, High Grade Malignant Tumor Trial in

Completed
  • Blasts 10 Percent or More of Bone Marrow Nucleated Cells
  • +8 more
  • Cladribine
  • +13 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 11, 2021

Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo, Rebif® new formulation (RNF))

Completed
  • Multiple Sclerosis
  • Cladribine
  • +2 more
  • Phoenix, Arizona
  • +157 more
Feb 24, 2021

Hodgkin Lymphoma, Non-hodgkin Lymphoma Trial (Chidamide, Cladribine, gemcitabine)

Unknown status
  • Hodgkin Lymphoma
  • Non-hodgkin Lymphoma
  • (no location specified)
Jul 25, 2018

Leukemia, Myeloid, Acute Trial in United States (DFP-10917, Cytarabine, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +38 more
Dec 25, 2021

Lymphocytic Leukemia, Chronic Trial in Belarus, Poland (Cladribine, Cyclophosphamide, Rituximab)

Completed
  • Lymphocytic Leukemia, Chronic
  • Cladribine
  • +2 more
  • Minsk, Belarus
  • +5 more
Nov 17, 2017

Lymphoma Trial in China (Chidamide, Cladribine, gemcitabine)

Unknown status
  • Lymphoma
  • Beijing, Beijing, China
  • +17 more
Jul 16, 2018

Mantle Cell Lymphoma Trial in Hershey (Rituximab, bortezomib, Cladribine)

Unknown status
  • Mantle Cell Lymphoma
  • Hershey, Pennsylvania
  • +1 more
Aug 4, 2017

Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma Trial in Milan (Rituximab, Cladribine)

Terminated
  • Chronic Lymphocytic Leukaemia
  • Small Lymphocytic Lymphoma
  • Milan, Italy
    European Institute of Oncology
Jan 30, 2018

Lymphoma Trial (rituximab, cladribine)

Completed
  • Lymphoma
  • rituximab
  • cladribine
  • (no location specified)
Dec 5, 2016

Lymphoma Trial in United States (rituximab, cladribine, temsirolimus)

Completed
  • Lymphoma
  • rituximab
  • +4 more
  • Scottsdale, Arizona
  • +143 more
Jan 8, 2018

Lymphoma Trial in Canada, United States (cladribine)

Completed
  • Lymphoma
  • cladribine
  • Scottsdale, Arizona
  • +20 more
Dec 5, 2016

Multiple Sclerosis Trial (Cladribine, Pantoprazole)

Completed
  • Multiple Sclerosis
  • (no location specified)
Mar 15, 2016

Brain and CNS Tumors Trial run by the NCI (chemo, cladribine, radiation therapy)

Completed
  • Brain and Central Nervous System Tumors
  • Bethesda, Maryland
    Radiation Oncology Branch
Apr 28, 2015

Leukemia Trial in Detroit, Grosse Pointe Woods (bryostatin 1, cladribine)

Completed
  • Leukemia
  • bryostatin 1
  • cladribine
  • Detroit, Michigan
  • +2 more
Apr 22, 2014

Leukemia Trial in Rochester (filgrastim, cladribine, cytarabine)

Completed
  • Leukemia
  • filgrastim
  • +3 more
  • Rochester, New York
    James P. Wilmot Cancer Center at University of Rochester Medical
Oct 14, 2013

Leukemia, Myeloid, Acute Trial in St. Louis (Granulocyte colony-stimulating factor (G-CSF), Cladribine, Cytarabine)

Completed
  • Leukemia, Myeloid, Acute
  • Granulocyte colony-stimulating factor (G-CSF)
  • +4 more
  • St. Louis, Missouri
    Washington University School of Medicine
Jul 22, 2013

Leukemia Trial in Australia, Canada, United States (biological, drug, procedure, radiation)

Completed
  • Leukemia
  • filgrastim
  • +12 more
  • Long Beach, California
  • +37 more
Jul 23, 2014

Leukemia Trial in Switzerland (filgrastim, rituximab, CHOP regimen)

Completed
  • Leukemia
  • filgrastim
  • +7 more
  • Aarau, Switzerland
  • +10 more
May 14, 2012